Corticotropin-releasing hormone or dexamethasone regulates rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter

Journal of Endocrinology

Volumn 193, Issue 2, 2007, Pages 279-290

  Murakami, Itsuo ^a   Takeuchi, Sakae ^a   Kudo, Toshiyuki ^b   Sutou, Shizuyo ^b   Takahashi, Sumio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CALCIUM; CALCIUM CHANNEL L TYPE; CALMODULIN; CELL NUCLEUS RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DEXAMETHASONE; DNA FRAGMENT; GLUCOCORTICOID; LUCIFERASE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NIFEDIPINE; NUCLEAR RECEPTOR NUR RESPONSIVE ELEMENT; NUCLEAR RECEPTOR NUR77; PROOPIOMELANOCORTIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX1; TRANSCRIPTION FACTOR TPIT; UNCLASSIFIED DRUG; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE 2; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DRUG DERIVATIVE; HOMEOBOX PROTEIN PITX1; HOMEODOMAIN PROTEIN; MESSENGER RNA; PAIRED BOX TRANSCRIPTION FACTOR; PROTEIN KINASE (CALCIUM,CALMODULIN); SULFONAMIDE; T BOX TRANSCRIPTION FACTOR; TBX19 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN INTERACTION; RAT; REPORTER GENE; TANDEM REPEAT; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; DRUG ANTAGONISM; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNEL BLOCKERS; CALMODULIN; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; DEXAMETHASONE; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HOMEODOMAIN PROTEINS; NIFEDIPINE; PAIRED BOX TRANSCRIPTION FACTORS; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; T-BOX DOMAIN PROTEINS; TRANSFECTION;

EID: 34250318916     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-06-0143     Document Type: Article

References (48)

1. Affolter HU & Reisine T 1985 Corticotropin releasing factor increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells. Journal of Biological Chemistry 260 15477-15481.
2. Aguilera G, Harwood JP, Wilson JX, Morell J, Brown JH & Catt KJ 1983 Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. Journal of Biological Chemistry 258 8039-8045.
3. Aoki Y, Iwasaki Y, Katahira M, Oiso Y & Saito H 1997 Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: effects of the common secretagogues. Endocrinology 138 1923-1929.
4. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J et al. 2006 Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes and Development 20 2871-2886.
5. Birnberg NC, Lissitzky JC, Hinman M & Herbert E 1983 Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion. PNAS 80 6982-6986.
6. De Bosscher K, Vanden Berghe W & Haegeman G 2003 The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocrine Reviews 24 488-522.
7. Boutillier AL, Monnier D, Lorang D, Lundblad JR, Roberts JL & Loeffler JP 1995 Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1. Molecular Endocrinology 9 745-755.
8. Bruhn TO, Sutton RE, Rivier CL & Vale WW 1984 Corticotropin-releasing factor regulates proopiomelanocortin messenger ribonucleic acid levels in vivo. Neuroendocrinology 39 170-175.
9. Cadepond F, Schweizer-Groyer G, Segard-Maurel I, Jibard N, Hollenberg SM, Giguere V, Evans RM & Baulieu EE 1991 Heat shock protein 90 as a critical factor in maintaining glucocorticosteroid receptor in a nonfunctional state. Journal of Biological Chemistry 266 5834-5841.
10. Dostert A & Heinzel T 2004 Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Current Pharmaceutical Design 10 2807-2816.
11. von Dreden G, Loeffler JP, Grimm C & Hollt V 1988 Influence of calcium ions on proopiomelanocortin mRNA levels in clonal anterior pituitary cells. Neuroendocrinology 47 32-37.
12. Drouin J, Trifiro MA, Plante RK, Nemer M, Eriksson P & Wrange O 1989a Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Molecular and Cellular Biology 9 5305-5314.
13. Drouin J, Nemer M, Charron J, Gagner JP, Jeannette L, Sun YL, Therrien M & Tremblay Y 1989b Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids. Genome 31 510-519.
14. Eberwine JH & Roberts JL 1984 Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary. Journal of Biological Chemistry 259 2166-2170.
15. Farrell WE, Stewart ME Clark AJ, Crosby SR, Davis JR & White A 1993 Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells. Journal of Molecular Endocrinology 10 25-32.
16. Gagner JP & Drouin J 1985 Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Molecular and Cellular Endocrinology 40 25-32.
17. Gagner JP & Drown J 1987 Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate, and glucocorticoids. Molecular Endocrinology 1 677-682.
18. Giguere V, Labrie F Cote J, Coy DH, Sueiras-Diaz J & Schally AV 1982 Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. PNAS 79 3466-3469.
19. Grammatopoulos DK & Chrousos GP 2002 Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends in Endocrinology and Metabolism 13 436-444.
20. Hammer GD, Fairchild-Huntress V & Low MJ 1990 Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice. Molecular Endocrinology 4 1689-1697.
21. Jeannette L, Trifiro MA, Plante RK, Chamberland M & Drouin J 1987 Tissue-specific activity of the pro-opiomelanocortin gene promoter. Molecular and Cellular Biology 7 4058-4064.
22. Keller-Wood ME & Dallman MF 1984 Corticosteroid inhibition of ACTH secretion. Endocrine Reviews 5 1-24.
23. Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F & Arzt E 2002 Activation and induction of NUR77/NURR1 in corticotrophsby CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Molecular Endocrinology 16 1638-1651.
24. Kumar R & Thompson EB 2005 Gene regulation by the glucocorticoid receptor: structure:function relationship. Journal of Steroid Biochemistry and Molecular Biology 94 383-394.
25. 2+ channels in rat corticotropes. Endocrinology 137 2269-2277.
26. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A & Drouin J 2001 A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104 849-859.
27. 2+ rise in identified rat corticotrophs. Journal of Physiology 504 367-378.
28. Litvin Y, PasMantier R, Fleischer N & Erlichman J 1984 Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin. Journal of Biological Chemistry 259 10296-10302.
29. Liu B, Hammer GD, Rubinstein M, Mortrud M & Low MJ 1992 Identification of DNA elements cooperatively activating proopiomelanocortin gene expression in the pituitary glands of transgenic mice. Molecular and Cellular Biology 12 3978-3990.
30. Loeffler JP, Kley N, Pittius CW & Hollt V 1986 Calcium ion and cyclic adenosine 3′,5′-monophosphate regulate proopiomelanocortin messenger ribonucleic acid levels in rat intermediate and anterior pituitary lobes. Endocrinology 119 2840-2847.
31. Maira M, Martens C, Philips A & Drouin J 1999 Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Molecular and Cellular Biology 19 7549-7557.
32. Maira M, Martens C, Batsche E, Gauthier Y & Drouin J 2003a Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Molecular and Cellular Biology 23 763-776.
33. Maira M, Couture C, Le Martelot G, Pulichino AM, Bilodeau S & Drouin J 2003b The T-box factor Tpit recruits SRC/p160 co-activators and mediates hormone action. Journal of Biological Chemistry 278 46523-46532.
34. Martens C, Bilodeau S, Maira M, Gauthier Y & Drouin J 2005 Protein-Protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Molecular Endocrinology 19 885-897.
35. Mynard V, Latchournanin O, Guignat L, Devin-Leclerc J, Bertagna X, Barre B, Fagart J, Coqueret O & Catelli MG 2004 Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3′,5′-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter. Molecular Endocrinology 18 2997-3010.
36. Nikodemova M, Kasckow J, Liu H, Manganiello V & Aguilera G 2003 Cyclic adenosine 3′,5′-monophosphate regulation of corticotropin-releasing hormone promoter activity in AtT-20 cells and in a transformed hypothalamic cell line. Endocrinology 144 1292-1300.
37. Nudi M, Ouimette JF & Drouin J 2005 BMP (Smad)-mediated repression of POMC transcription by interference with Pitx/Tpit activity. Molecular Endocrinology 19 1329-1342.
38. Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P & Drouin J 1997a Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Molecular and Cellular Biology 17 5946-5951.
39. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P & Drouin J 1997b Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Molecular and Cellular Biology 17 5952-5959.
40. Picard D & Yamamoto KR 1987 Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO Journal 6 3333-3340.
41. Pulichino AM, Vallette-Kasic S, Tsai JP, Couture C, Gauthier Y & Drouin J 2003a Tpit determines alternate fates during pituitary cell differentiation. Genes and Development 17 738-747.
42. Pulichino AM, Vallette-Kasic S, Couture C, Gauthier Y, Brue T, David M, Matpuech G, Deal C, Van Vliet G, De Vroede M et al. 2003b Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency, Genes and Development 17 711-716.
43. Ray DW, Ren SG & Melmed S 1996 Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Pole of STAT pathway. Journal of Clinical Investigation 97 1852-1859.
44. Reily MM, Pantoja C, Hu X, Chinenov Y & Rogatsky I 2006 The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO Journal 25 108-117.
45. Reisine T, Rougon G, Barber J & Affolter HU 1985 Corticotropin-releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes. PNAS 82 8261-8265.
46. Rogatsky I, Luecke HF, Leitman DC & Yamamoto KR 2002 Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. PNAS 99 16701-16706.
47. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F & Wurst W 1998 Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics 19 162-166.
48. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le Fur G, Caput D & Ferrara P 1993 Primary structure and functional expression of mouse pituitary and human brain corricotrophin releasing factor receptors. FEBS Letters 335 1-5.